← Back to Search

Cholinesterase Inhibitor

Donepezil 5-10 Mg Oral Tablet for Type 2 Diabetes

Phase 2

Waitlist Available

Research Sponsored by University of Maryland, Baltimore

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial is testing whether the drug Donepezil is effective in treating Type 2 Diabetes Mellitus compared to a control treatment. 50 patients will be given either Donepezil or a placebo, and the results will be observed over 8 weeks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Hemoglobin A1C

Secondary outcome measures

Change in blood urea nitrogen

Change in creatinine

Other outcome measures

Change in albumin

Change in lipid profile

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Donepezil treatment groupExperimental Treatment1 Intervention

Administration of 5mg or 10 mg of donepezil daily

Group II: Control groupPlacebo Group1 Intervention

Administration of placebo

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor

688 Previous Clinical Trials

374,649 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there similarDonepezil 5-10 Mg Oral Tablet clinical trials that have already been completed?

"At the moment, 16 different clinical trials are underway to research Donepezil 5-10 Mg Oral Tablet. Out of those 16 live trials, 3 are in Phase 3. Although many of the clinical trials for Donepezil 5-10 Mg Oral Tablet originate from Hallandale Beach, Florida - there are 31 locations conducting these studies in total."

Answered by AI

Are medical staff still looking for volunteers for this experiment?

"Yes, the latest information on clinicaltrials.gov suggests that this research is actively recruiting patients. The trial was first posted online on July 12th, 2019 and has been updated as recently as October 20th, 2021. A total of 50 people are needed for the study taking place at 1 location."

Answered by AI

Why is Donepezil 5-10 Mg Oral Tablet prescribed so often?

"The most popular treatment for alzheimer's disease is Donepezil 5-10 Mg Oral Tablet. However, this medication can also be used to mitigate the symptoms of other degenerative cognitive diseases like mild dementia of the alzheimer's type, vascular dementia, and Lewy body dementia."

Answered by AI

Has the FDA cleared Donepezil 5-10 Mg Oral Tablet for public use?

"There is some evidence from prior clinical trials that Donepezil 5-10 Mg Oral Tablet is safe, but none supporting that it is effective. Therefore, it received a score of 2."

Answered by AI

How many test subjects are participating in this trial?

"That is correct, the clinicaltrials.gov website does show that this trial is actively looking for participants. The study was first posted on 7/12/2019 and was last updated on 10/20/2021. They are hoping to find 50 patients at 1 site."

Answered by AI

Is this a clinical trial that is groundbreaking and innovative?

"Since 2013, Donepezil 5-10 Mg Oral Tablet has been the focus of 16 live clinical trials spread out over 7 countries and 21 cities. The very first study was sponsored by Dong-A Pharmaceutical Co., Ltd. back in 2013 and it only involved 210 patients. However, after this initial research was completed, Donepezil 5-10 Mg Oral Tablet received approval for Phase 3 drug testing."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effect of Donepezil on Glycemic Control in Type II Diabetics

Stephen Wills 2019. "The Effect of Donepezil on Glycemic Control in Type II Diabetics". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04507438.